ISR Projects the 2014 CRO Market to Be Worth $23.6 Billion

Informing the Drug Development and Commercialization Industry

CARY, NC--(Marketwired - Feb 4, 2014) - Industry Standard Research (ISR) has announced the availability of a new report titled "2014 CRO Market Size Projections: 2012-2018." For this report, ISR has utilized both publically available information and data obtained through their syndicated primary market research to provide a thorough, rational analysis of the clinical development services outsourcing market segmented by phase, geography, and service line.

"To better understand what is impacting CRO revenue and opportunity, ISR uses a top-down approach that starts with total R&D spend, isolates development spend, narrows that to Phase I-IV spend, and ends with the market available to CROs," explained Andrew Schafer, President of ISR. "ISR's unique access to high-quality primary market research data is what makes our forecasting different. It allows us to not only speak to the size of the overall CRO market, we also segment this by geographic region, service line, and study phase. This is something all service providers need."

Schafer continues, "Recent years have seen an industry growth rate around 5.5%. However, our data show the market increasing at a rate of 7.9% from 2014 to 2018. The increasing growth rate is primarily attributable to an increase in the penetration of outsourcing. With the data that comes from several of the industry leaders entering the public market, coupled with ISR's primary market research data, ISR feels confident we have provided intelligent projections for the CRO market size."

For more information on ISR's "2014 CRO Market Size Projections: 2012-2018" report, please visit ISR's report page at

As part of our mission to be the industry's go-to source for market data, ISR provides and updates a free repository of core pharmaceutical industry metrics. For more information on ISR's Core Industry Metrics, please visit

About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit the company's Web site at, email, or follow us on Twitter @ISRreports.

Contact Information:

Andrew Schafer

+1 (919) 301-0106

ISR 2014 CRO Market Size